John Sliwka
About John Sliwka
John Sliwka is the VP of US Market Access at Komodo Health, with over 26 years of experience in commercial healthcare and expertise in managed care, pricing, and trade.
Company
John Sliwka currently serves as the Vice President of US Market Access at Komodo Health. His role involves overseeing strategies to ensure market access for healthcare solutions within the US. Komodo Health utilizes data-driven tools to provide insights into the healthcare industry, enhancing patient outcomes and system efficiencies.
Title
John Sliwka holds the position of Vice President of US Market Access at Komodo Health. With a substantial history in market access roles, he brings extensive expertise in payer marketing and patient reimbursement strategies to his current position.
Previous Roles
John has held several significant positions throughout his career. At ICON plc, he was the Global Head of Market Access from 2020 to 2022. Prior to that, he was the VP of US Market Access at Myovant Sciences from 2019 to 2020. From 2016 to 2019, he served as the Head of Market Access & Trade at MannKind Corporation in Westlake Village, CA. At Bristol Myers Squibb, he occupied various roles including Regional Business Director, West Region, and Director of Market Access Strategy. Earlier in his career, he held multiple positions at Novo Nordisk, including Director of Managed Markets Strategy and Biopharmaceutical Sales Manager.
Education and Expertise
John Sliwka earned a Bachelor of Science degree with dual emphases in Finance and Management from California State University, Chico, graduating in 1993. He has over 26 years of experience in the commercial healthcare sector, with 18 years specifically focused on managed care, pricing, and trade. His specialized knowledge extends to developing innovative payer marketing solutions and ensuring profitable market access across various therapeutic areas.
Key Competencies and Experience
John has developed innovative launch strategies to ensure profitable market access across all payer channels, focusing on specialty products in therapeutic areas like immunology, oncology, diabetes, and rare diseases. His extensive background includes a keen understanding of payer marketing solutions aimed at optimizing patient reimbursement and reducing prescribing barriers. He has established deep relationships with payer Key Opinion Leaders (KOLs), which bolster his strategies in market access and pricing.